Clinical Trial Update: Safety of Darbepoetin Alfa Treatment in Patients With Severe Traumatic Brain Injury [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 safety evaluation of darbepoetin alfa in patients with severe traumatic brain injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Royal Alexandra Hospital | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED